REQUEST A DEMO
Total
USD $0.00
Search more companies

Polaris Group (北极星药业集团股份有限公司) (Taiwan, China)

Main Activities: Pharmaceutical and Medicine Manufacturing
Full name: Polaris Group Profile Updated: June 18, 2025
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English & Chinese Download a sample report

Polaris Group (北极星药业集团股份有限公司) is based in Taiwan, China. The head office is in Taipei City. The company operates in the Pharmaceutical and Medicine Manufacturing industry. It was established on February 09, 2006. 151 (2023) employees currently work for Polaris Group (北极星药业集团股份有限公司). In Q3C2025, the company reported a net sales revenue drop of 51.12%. Its total assets decreased by 1.4% over the same period. In 2025, Polaris Group (北极星药业集团股份有限公司)’s net profit margin decreased by 4147.75%.

Headquarters
7F, No.298, Ruiguang Rd., Neihu Dist
Taipei City; Taipei City;

Contact Details: Purchase the Polaris Group (北极星药业集团股份有限公司) report to view the information.

Website: http://www.polarispharma.com

Basic Information
Total Employees:
Purchase the Polaris Group (北极星药业集团股份有限公司) report to view the information.
Outstanding Shares:
Purchase the Polaris Group (北极星药业集团股份有限公司) report to view the information.
Financial Auditors:
Purchase the Polaris Group (北极星药业集团股份有限公司) report to view the information.
Incorporation Date:
February 09, 2006
Key Executives
Purchase this report to view the information.
Chairman
Purchase this report to view the information.
Chief Executive Officer
Ownership Details
Purchase this report to view the information.
39.01%
Purchase this report to view the information.
5.45%
Purchase this report to view the information.
0.67%
Purchase this report to view the information.
Purchase this report to view the information.
Subsidiaries
Designerx Europe Limited (United Kingdom)
100%
Designerx Pharmaceuticals, Inc (United States)
100%
Polaris Pharmaceuticals Australia Pty Ltd. (Australia)
100%
Company Performance
Financial values in the chart are available after Polaris Group (北极星药业集团股份有限公司) report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency TWD. Absolute financial data is included in the purchased report.
Net sales revenue
-51.12%
Total operating revenue
13.09%
Operating profit (EBIT)
-26.24%
EBITDA
-11.87%
Net Profit (Loss) for the Period
-33.46%
Total assets
-1.4%
Total equity
-32.06%
Operating Profit Margin (ROS)
-3986.07%
Net Profit Margin
-4147.75%
Return on Equity (ROE)
-26.52%
Debt to Equity Ratio
56.72%
Quick Ratio
-5.28%
Cash Ratio
-3.19%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?